Esperion Therapeutics soars amid vague takeover speculation
Esperion Therapeutics soars amid vague takeover speculation
#earnings before the open tomorrow https://t.co/lObOE0dgsr $FSR $NKLA $NVAX $PLUG $DOCN $UAA $AMCX $EVGO $COTY $BLUE $DUK $J $SQSP $APD $FOXA $OTLY $GFS $ARMK $LEV $XXII $MRSN $ASC $NXST $WE $HR $IGT $CHH $CTLT $WRBY $CRON $TDG $VTNR $WHD $ESPR $SEAS $YOU $VYGR $ASRT $TH $WMG… https://t.co/TVmruTfhOC
278.47MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US29664W1053
CUSIP
29664W105
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-4.78
Book Value
-2.17
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.91
Wall Street Target Price
5.79
EPS Estimate Current Year
-0.24
EPS Estimate Next Year
-0.14
EPS Estimate Current Quarter
-0.15
EPS Estimate Next Quarter
-0.13
Most Recent Quarter
-
Revenue TTM
259,574,000
Gross Profit TTM
124,118,000
EBITDA
-39,915,000
Profit Margin
-59.03%
Return On Assets TTM
-7.17%
Return On Equity TTM
-260.79%
Revenue Per Share TTM
1.339
Qtly Revenue Growth YOY
-52.80%
Diluted Eps TTM
-0.91
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
1
Price Sales TTM
1.1377
Price Book MRQ
98.4236
Enterprise Value Revenue
1
Enterprise Value EBITDA
48
164.96
8.53%126.55
1.24%25.21
1.00%14.30
0.95%15.71
0.16%163.60
0.00%55.62
0.00%14.00
0.00%27.50
0.00%9.34
-1.84%